Authors

Ellen Sher, MD | Credit: Allergy Partners

Ellen Sher, MD, is an allergist and immunologist with Allergy Partners of New Jersey.

Victoria Grant, PharmD, is a second-year infectious diseases pharmacotherapy fellow at Loma Linda University Medical Center in California and is the pharmacy champion for the implementation of T2Candida. Her interests include transplant infectious diseases, rapid diagnostics, and antimicrobial stewardship.

Michael D. Clayman, MD, is chief executive officer and co-founder, Flexion Therapeutics.

Ryan Livingston joined the MJH Life Sciences team in March of 2025, shortly after graduating from TCNJ with a bachelor’s degree in English. He enjoys creative writing, reading, and scuba diving. He can be reached at [email protected].

Brittany Craiglow, MD, is a dermatologist and an Associate Professor Adjunct - Dermatology at Yale School of Medicine.

Alicia Sullivan is Practice Manager, Rheumatology Associates and Vice President, NORM

Professor Eric Morand, MD, PhD, is head of the School of Clinical Sciences at Monash Health, Monash University's largest clinical school, and a physician-scientist.

He specializes in the study of systemic lupus erythematosus. He is founder of the Monash Lupus Clinic, Australia's largest research-grounded clinic for patients with SLE, a founding member of the Australian Lupus Registry & Biobank, and Chair of the Asia-Pacific Lupus Collaboration. His clinical research focuses on improving endpoints for clinical research in lupus. His lab has studied the biology of glucocorticoids in rheumatic disease and lupus since 1996.

He is a clinical rheumatologist, and head of the Monash Health Rheumatology Unit, the largest in Australia.

Assistant Professor, Department of Health Policy and Management, Columbia University Mailman School of Public Health